BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12209475)

  • 1. Biophysical methods to study ligand-receptor interactions of neuropeptide Y.
    Bettio A; Beck-Sickinger AG
    Biopolymers; 2001; 60(6):420-37. PubMed ID: 12209475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and dynamics of micelle-bound neuropeptide Y: comparison with unligated NPY and implications for receptor selection.
    Bader R; Bettio A; Beck-Sickinger AG; Zerbe O
    J Mol Biol; 2001 Jan; 305(2):307-29. PubMed ID: 11124908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural similarities of micelle-bound peptide YY (PYY) and neuropeptide Y (NPY) are related to their affinity profiles at the Y receptors.
    Lerch M; Mayrhofer M; Zerbe O
    J Mol Biol; 2004 Jun; 339(5):1153-68. PubMed ID: 15178255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of the structure of the N-terminal domain from the Y4 receptor - a G protein-coupled receptor - and its interaction with hormones from the NPY family.
    Zou C; Kumaran S; Markovic S; Walser R; Zerbe O
    Chembiochem; 2008 Sep; 9(14):2276-84. PubMed ID: 18767100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPC receptors and not ligands decide the binding mode in neuropeptide Y multireceptor/multiligand system.
    Lindner D; van Dieck J; Merten N; Mörl K; Günther R; Hofmann HJ; Beck-Sickinger AG
    Biochemistry; 2008 Jun; 47(22):5905-14. PubMed ID: 18457425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling of neuropeptide receptors Y1, Y4, Y5, and docking studies with neuropeptide antagonist.
    Jois SD; Nagarajarao LM; Prabhakaran M; Balasubramaniam A
    J Biomol Struct Dyn; 2006 Apr; 23(5):497-508. PubMed ID: 16494499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family.
    Cabrele C; Beck-Sickinger AG
    J Pept Sci; 2000 Mar; 6(3):97-122. PubMed ID: 10759209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards understanding the free and receptor bound conformation of neuropeptide Y by fluorescence resonance energy transfer studies.
    Haack M; Beck-Sickinger AG
    Chem Biol Drug Des; 2009 Jun; 73(6):573-83. PubMed ID: 19635049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prokaryotic expression, in vitro folding, and molecular pharmacological characterization of the neuropeptide Y receptor type 2.
    Schmidt P; Lindner D; Montag C; Berndt S; Beck-Sickinger AG; Rudolph R; Huster D
    Biotechnol Prog; 2009; 25(6):1732-9. PubMed ID: 19725122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strongly altered receptor binding properties in PP and NPY chimeras are accompanied by changes in structure and membrane binding.
    Lerch M; Kamimori H; Folkers G; Aguilar MI; Beck-Sickinger AG; Zerbe O
    Biochemistry; 2005 Jun; 44(25):9255-64. PubMed ID: 15966750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of the human neuropeptide Y Y2-receptor.
    Ingenhoven N; Eckard CP; Gehlert DR; Beck-Sickinger AG
    Biochemistry; 1999 May; 38(21):6897-902. PubMed ID: 10346911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of prejunctional receptor binding analog of human neuropeptide Y dimer ANA-NPY.
    Barden JA
    Biochem Biophys Res Commun; 1995 Oct; 215(1):264-71. PubMed ID: 7575600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional role of the extracellular N-terminal domain of neuropeptide Y subfamily receptors in membrane integration and agonist-stimulated internalization.
    Lindner D; Walther C; Tennemann A; Beck-Sickinger AG
    Cell Signal; 2009 Jan; 21(1):61-8. PubMed ID: 18845246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular recognition of the NPY hormone family by their receptors.
    Lindner D; Stichel J; Beck-Sickinger AG
    Nutrition; 2008 Sep; 24(9):907-17. PubMed ID: 18725086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of covalent dimerization on the structure and function of the carboxy-terminal fragment of neuropeptide Y.
    Uegaki K; Murase S; Nemoto N; Kobayashi Y; Yoshikawa S; Yumoto N
    Biochem Biophys Res Commun; 1997 Dec; 241(3):737-43. PubMed ID: 9434778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel modified and radiolabelled neuropeptide Y analogues to study Y-receptor subtypes.
    Koglin N; Beck-Sickinger AG
    Neuropeptides; 2004 Aug; 38(4):153-61. PubMed ID: 15337368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple and powerful flow cytometric method for the simultaneous determination of multiple parameters at G protein-coupled receptor subtypes.
    Schneider E; Mayer M; Ziemek R; Li L; Hutzler C; Bernhardt G; Buschauer A
    Chembiochem; 2006 Sep; 7(9):1400-9. PubMed ID: 16888730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the C terminus in neuropeptide Y Y1 receptor desensitization and internalization.
    Holliday ND; Lam CW; Tough IR; Cox HM
    Mol Pharmacol; 2005 Mar; 67(3):655-64. PubMed ID: 15576634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional reconstitution of human neuropeptide Y (NPY) Y(2) and Y(4) receptors in Sf9 insect cells.
    Pop N; Igel P; Brennauer A; Cabrele C; Bernhardt GN; Seifert R; Buschauer A
    J Recept Signal Transduct Res; 2011 Aug; 31(4):271-85. PubMed ID: 21745157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of a fully active class A G protein-coupled receptor isolated from in vitro folding.
    Bosse M; Thomas L; Hassert R; Beck-Sickinger AG; Huster D; Schmidt P
    Biochemistry; 2011 Nov; 50(45):9817-25. PubMed ID: 21999704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.